The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Open accessAbstract
The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals 1–3 . Despite the reduced protection from infection, individuals who received three doses of an mRNA vaccine were highly protected from more serious consequences of infection 4 . Here we examine the memory B cell repertoire in a longitudinal cohort of individuals receiving three mRNA vaccine doses 5,6 . We find that the third dose is accompanied by an increase in, and evolution of, receptor-binding domain (RBD)-specific memory B cells. The increase is due to expansion of memory B cell clones that were present after the second dose as well as the emergence of new clones. The antibodies encoded by these cells showed significantly increased potency and breadth when compared with antibodies obtained after the second dose. Notably, the increase in potency was especially evident among newly developing clones of memory cells, which differed from persisting clones in targeting more conserved regions of the RBD. Overall, more than 50% of the analysed neutralizing antibodies in the memory compartment after the third mRNA vaccine dose neutralized the Omicron variant. Thus, individuals receiving three doses of an mRNA vaccine have a diverse memory B cell repertoire that can respond rapidly and produce antibodies capable of clearing even diversified variants such as Omicron. These data help to explain why a third dose of a vaccine that was not specifically designed to protect against variants is effective against variant-induced serious disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A booster serves as a re-exposure to the virus, which creates new antibodies as well as additional and improved memory B-cells responses to fight off future infections.”
From Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024 (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has even been found that booster exposure also improves the ability of the memory B-cells to recognise unknown variants such as the Omicron strain [18, 20].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
Sievers, F., Wilm, A., Dineen, D., Gibson, T., Karplus, K., Li, W.-Z., Lopez, R., McWilliam, H., Remmert, M., Söding, J., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.75 · Cited by 15,576
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Self-citationA serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Self-citationREGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
Weinreich, D. M., Sivapalasingam, S., Norton, T., Ali, S., Gao, H., Bhore, R., Musser, B. J., Soo, Y., Rofail, D., Im, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035002 · Cited by 1,642
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M. A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., et al. (2020) · Nature · doi:10.1038/s41586-020-2852-1 · Cited by 1,599
Self-citationConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures
Landau, M., Mayrose, I., Rosenberg, Y., Glaser, F., Martz, E., Pupko, T., & Ben‐Tal, N. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki370 · Cited by 1,379
Cited by
Sorted by citations
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Cao, Y., Yisimayi, A., Jian, F., Song, W., Xiao, T., Wang, L., Du, S., Wang, J., Li, Q., Chen, X., et al. (2022) · Nature · doi:10.1038/s41586-022-04980-y · Cited by 1,306
Vaccination induces HIV broadly neutralizing antibody precursors in humans
Leggat, D. J., Cohen, K. W., Willis, J. R., Fulp, W. J., deCamp, A. C., Kalyuzhniy, O., Cottrell, C. A., Menis, S., Finak, G., Ballweber-Fleming, L., et al. (2022) · Science · doi:10.1126/science.add6502 · Cited by 293
Irrgang, P., Gerling, J., Kocher, K., Lapuente, D., Steininger, P. A., Habenicht, K. M., Wytopil, M., Beileke, S., Schäfer, S., Zhong, J., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.ade2798 · Cited by 269
mRNA vaccines in disease prevention and treatment
Zhang, G., Tang, T., Chen, Y., Huang, X., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01579-1 · Cited by 273
Inoue, T., & Kurosaki, T. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00897-3 · Cited by 245
Chi, W.-Y., Li, Y.-D., Huang, H., Chan, T. E. H., Chow, S.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00853-8 · Cited by 225
A guide to adaptive immune memory
Lam, N., Lee, Y. S., & Färber, D. L. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01040-6 · Cited by 236
Quandt, J., Muik, A., Salisch, N. C., Lui, B. G., Lutz, S., Krüger, K., Wallisch, A.-K., Adams‐Quack, P., Bacher, M., Finlayson, A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq2427 · Cited by 194
The humoral response and antibodies against SARS-CoV-2 infection
Qi, H., Liu, B., Wang, X., & Zhang, L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01248-5 · Cited by 195
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Alsoussi, W. B., Malladi, S. K., Zhou, J. Q., Liu, Z., Ying, B., Kim, W., Schmitz, A. J., Lei, T., Horvath, S. C., Sturtz, A. J., et al. (2023) · Nature · doi:10.1038/s41586-023-06025-4 · Cited by 174
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination
Schaefer-Babajew, D. J., Wang, Z., Muecksch, F., Cho, A., Loewe, M., Cipolla, M., Raspe, R., Johnson, B., Canis, M., DaSilva, J., et al. (2022) · Nature · doi:10.1038/s41586-022-05609-w · Cited by 172
Self-citationAntibody-mediated neutralization of SARS-CoV-2
Gruell, H., Vanshylla, K., Weber, T., Barnes, C. O., Kreer, C., & Klein, F. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.005 · Cited by 150
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection
Kaku, C. I., Bergeron, A. J., Ahlm, C., Normark, J., Sakharkar, M., Forsell, M. N. E., & Walker, L. M. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq3511 · Cited by 135
Tortorici, M. A., Addetia, A., Seo, A. J., Brown, J. T., Sprouse, K., Logue, J., Clark, E., Franko, N., Chu, H. Y., & Veesler, D. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.016 · Cited by 127
Adams, K., Rhoads, J. P., Surie, D., Gaglani, M., Ginde, A. A., McNeal, T., Talbot, H. K., Casey, J. D., Zepeski, A., Shapiro, N. I., et al. (2022) · BMJ · doi:10.1136/bmj-2022-072065 · Cited by 115
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Abulsoud, A. I., El‐Husseiny, H. M., El-Husseiny, A. A., El‐Mahdy, H. A., Ismail, A., Elkhawaga, S. Y., Khidr, E. G., Fathi, D., Mady, E. A., Najda, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113977 · Cited by 112
Painter, M. M., Johnston, T. S., Lundgreen, K. A., Santos, J. J. S., Qin, J. S., Goel, R. R., Apostolidis, S. A., Mathew, D., Fulmer, B., Williams, J. C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01613-y · Cited by 106
Regev‐Yochay, G., Lustig, Y., Joseph, G., Gilboa, M., Barda, N., Gens, I., Indenbaum, V., Halpern, O., Katz-Likvornik, S., Levin, T., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00012-5 · Cited by 109
Development of mRNA vaccines against respiratory syncytial virus (RSV)
Qiu, X., Xu, S., Lu, Y., Luo, Z., Yan, Y., Wang, C., & Ji, J. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.10.001 · Cited by 86
Antibody modulation of B cell responses—Incorporating positive and negative feedback
Cyster, J. G., & Wilson, P. C. (2024) · Immunity · doi:10.1016/j.immuni.2024.06.009 · Cited by 78
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
Jing, H., Wu, X., Xiang, M., Liu, L., Novakovic, V. A., & Shi, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.992384 · Cited by 81
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Li, D., Martinez, D. R., Schäfer, A., Chen, H., Barr, M., Sutherland, L. L., Lee, E., Parks, R., Mielke, D., Edwards, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33985-4 · Cited by 70
Li, M., Ren, Y., Aw, Z. Q., Chen, B., Yang, Z., Lei, Y., Cheng, L., Liang, Q., Hong, J., Yang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35642-2 · Cited by 72
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
Witte, L., Baharani, V. A., Schmidt, F., Wang, Z., Cho, A., Raspe, R., Guzmán-Cardozo, C., Muecksch, F., Canis, M., Park, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35927-0 · Cited by 68
Self-citationInstructing durable humoral immunity for COVID-19 and other vaccinable diseases
Bhattacharya, D. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.004 · Cited by 64
Immune imprinting and next-generation coronavirus vaccines
Huang, C. Q., Vishwanath, S., Carnell, G., Chan, A. C. Y., & Heeney, J. L. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01505-9 · Cited by 68
Wang, Z., Zhou, P., Muecksch, F., Cho, A., Tanfous, T. B., Canis, M., Witte, L., Johnson, B., Raspe, R., Schmidt, F., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221006 · Cited by 61
Self-citationBuckner, C. M., Kardava, L., Merhebi, O. E., Narpala, S., Serebryannyy, L., Lin, B. C., Wang, W., Zhang, X., de Assis, F. L., Kelly, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.032 · Cited by 66
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
Kaku, C. I., Starr, T. N., Zhou, P.-P., Dugan, H. L., Khalifé, P., Song, G., Champney, E. R., Mielcarz, D. W., Geoghegan, J. C., Burton, D. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38345-4 · Cited by 70
Recent insights into SARS‐CoV‐2 omicron variant
da Silva, S. J. R., Kohl, A., Pena, L., & Pardee, K. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2373 · Cited by 56
Role of the humoral immune response during COVID-19: guilty or not guilty?
Yaugel-Novoa, M., Bourlet, T., & Paul, S. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00569-w · Cited by 57
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2
Huang, K.-Y. A., Chen, X., Mohapatra, A., Nguyen, H. T. V., Schimanski, L. M., Tan, T. K., Rijal, P., Vester, S. K., Hills, R. A., Howarth, M. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35949-8 · Cited by 51
Luo, S., Zhang, J., Kreutzberger, A. J. B., Eaton, A., Edwards, R. J., Jing, C., Dai, H., Sempowski, G. D., Cronin, K. D., Parks, R., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.add5446 · Cited by 53
Yang, L., Beek, M. V., Wang, Z., Muecksch, F., Canis, M., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C., & Chakraborty, A. K. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112256 · Cited by 50
Self-citationVoss, W. N., Mallory, M. L., Byrne, P. O., Marchioni, J., Knudson, S. A., Powers, J. M., Leist, S. R., Dadonaite, B., Townsend, D. R., Kain, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101668 · Cited by 44
Inoue, T., Shinnakasu, R., Chie, K., Yamamoto, H. H., Sakakibara, S., Ono, C., Itoh, Y., Terooatea, T. W., Yamashita, K., Okamoto, T., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221786 · Cited by 46
Liu, Y., Wang, Z., Zhuang, X., Zhang, S., Chen, Z., Zou, Y., Sheng, J., Li, T., Tai, W., Yu, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37926-7 · Cited by 43
Self-citationPlanas, D., Staropoli, I., Porot, F., Guivel‐Benhassine, F., Handala, L., Prot, M., Bolland, W., Puech, J., Péré, H., Veyer, D. L., et al. (2022) · Med · doi:10.1016/j.medj.2022.09.010 · Cited by 40
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccinesPreprint
Bowen, J. E., Sprouse, K. R., Walls, A. C., Mazzitelli, I. G., Logue, J. K., Franko, N., Ahmed, K., Ansari, A. S., Cameroni, E., Gori, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.15.484542 · Cited by 38
Grigoryan, L., Feng, Y., Bellusci, L., Lai, L., Wali, B., Ellis, M. L., Yuan, M., Arunachalam, P. S., Hu, M., Kowli, S., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adi8039 · Cited by 43
Jia, Z., Wang, K., Xie, M., Wu, J., Hu, Y., Zhou, Y., Yisimayi, A., Fu, W., Wang, L., Liu, P., et al. (2024) · Protein & Cell · doi:10.1093/procel/pwae033 · Cited by 41
Mwimanzi, F. M., Lapointe, H. R., Cheung, P. K., Sang, Y., Yaseen, F., Umviligihozo, G., Kalikawe, R., Datwani, S., Omondi, F. H., Burns, L., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac199 · Cited by 40
Weber, T., Dähling, S., Rose, S., Affeldt, P., Vanshylla, K., Ullrich, L., Gieselmann, L., Teipel, F., Gruell, H., Cristanziano, V. D., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adk5845 · Cited by 36
Tarke, A., Ramezani-Rad, P., Neto, T. A. P., Lee, Y., Silva‐Moraes, V., Goodwin, B., Bloom, N. I., Siddiqui, L., Avalos, L., Frazier, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101583 · Cited by 38
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Medits, I., Springer, D. N., Graninger, M., Camp, J. V., Höltl, E., Aberle, S. W., Traugott, M. T., Hoepler, W., Deutsch, J., Lammel, O., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946318 · Cited by 37
Windsor, I. W., Tong, P., Lavidor, O., Moghaddam, A. S., McKay, L. G. A., Gautam, A. K., Chen, Y., MacDonald, E. A., Yoo, D. K., Griffths, A., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abo3425 · Cited by 37
Zhou, G., Dael, N., Verweij, S., Balafas, S., Mubarik, S., Oude Rengerink, K., Pasmooij, A. M. G., van Baarle, D., Mol, P. G. M., de Bock, G. H., et al. (2025) · European Respiratory Review · doi:10.1183/16000617.0222-2024 · Cited by 34
“It has even been found that booster exposure also improves the ability of the memory B-cells to recognise unknown variants such as the Omicron strain [18, 20].”
SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa
Abdullahi, A., Oladele, D. A., Owusu, M., Kemp, S. A., James, A. B., Salako, A. O., Fink, D., Ige, F. A., Ferreira, I. A. T. M., Meng, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33792-x · Cited by 31
Devaux, C. A., & Camoin‐Jau, L. (2023) · Viruses · doi:10.3390/v15051045 · Cited by 34
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies
Sheward, D. J., Pushparaj, P., Das, H., Greaney, A. J., Kim, C., Kim, S., Hanke, L., Hyllner, E., Dyrdak, R., Lee, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101577 · Cited by 31
King, S. M., Bryan, S. P., Hilchey, S. P., Wang, J., & Zand, M. S. (2023) · Pathogens · doi:10.3390/pathogens12020169 · Cited by 33
Microneedle technology for potential SARS-CoV-2 vaccine delivery
McNamee, M., Wong, S., Guy, O. J., & Sharma, S. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2209718 · Cited by 30
Raisinghani, N., Alshahrani, M., Gupta, G., & Verkhivker, G. M. (2024) · Viruses · doi:10.3390/v16091458 · Cited by 33
Structural Immunology of SARS ‐ CoV ‐2
Yuan, M., & Wilson, I. A. (2024) · Immunological Reviews · doi:10.1111/imr.13431 · Cited by 29
Guirakhoo, F., Wang, S., Wang, C. Y., Kuo, H. K., Peng, W. J., Liu, H., Wang, L., Johnson, M., Hunt, A., Hu, M. M., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac241 · Cited by 28
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Shen, J., Fan, J., Zhao, Y., Jiang, D., Niu, Z., Zhang, Z., & Cao, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159326 · Cited by 38
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
Lee, W. S., Tan, H., Reynaldi, A., Esterbauer, R., Koutsakos, M., Nguyen, J. T., Amarasena, T. H., Kent, H. E., Aggarwal, A., Turville, S. G., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg5301 · Cited by 32
Jackson, S., Marshall, J. L., Mawer, A., Ramon, R. L., Harris, S. A., Satti, I., Hughes, E., Preston-Jones, H., Puig, I. C., Longet, S., et al. (2024) · The Lancet Microbe · doi:10.1016/s2666-5247(24)00025-9 · Cited by 28
Aurisicchio, L., Brambilla, N., Cazzaniga, M. E., Bonfanti, P., Milleri, S., Ascierto, P. A., Capici, S., Vitalini, C., Girolami, F., Giacovelli, G., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.12.017 · Cited by 29
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
de Assis, F. L., Hoehn, K. B., Zhang, X., Kardava, L., Smith, C. D., Merhebi, O. E., Buckner, C. M., Trihemasava, K., Wang, W., Seamon, C. A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112780 · Cited by 28
Liu, X., Li, Y., Wang, Z., Cao, S., Huang, W., Lin, Y., Huang, Y.-J., Zheng, Y. P., Chen, J., Ying, B., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00681-3 · Cited by 26
Self-citationZhou, R., Liu, N., Li, X., Peng, Q., Yiu, C.-K., Huang, H., Yang, D., Du, Z., Kwok, H.-Y., Au, K.-K., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100660 · Cited by 26
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
Sobhani, K., Cheng, S. C., Binder, R. A., Mantis, N. J., Crawford, J. M., Okoye, N. C., Braun, J. G., Joung, S. Y., Wang, M., Lozanski, G., et al. (2023) · Vaccines · doi:10.3390/vaccines11111644 · Cited by 26
Lenart, K., Cerveira, R. A., Hellgren, F., Ols, S., Sheward, D. J., Kim, C., Cagigi, A., Gagné, M., Davis, B. J., Germosen, D., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00806-2 · Cited by 26
Addetia, A., Piccoli, L., Case, J. B., Park, Y., Beltramello, M., Guarino, B., Dang, H. V., Pinto, D., Scheaffer, S. M., Sprouse, K. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.17.523798 · Cited by 25
The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages
Xiang, T., Wang, J., & Zheng, X. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.11.007 · Cited by 23
Andreano, E., Paciello, I., Pierleoni, G., Piccini, G., Abbiento, V., Antonelli, G., Pileri, P., Manganaro, N., Pantano, E., Maccari, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35781-6 · Cited by 24
Faliti, C. E., Van, T. T. P., Anam, F. A., Cheedarla, N., Williams, M. E., Mishra, A. K., Usman, S. Y., Woodruff, M. C., Kraker, G., Runnstrom, M. C., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-02010-9 · Cited by 23
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
Wang, Z., Muecksch, F., Münn, F., Cho, A., Zong, S., Raspe, R., Ramos, V., Johnson, B., Tanfous, T. B., DaSilva, J., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220826 · Cited by 24
Self-citationKotaki, R., Moriyama, S., Oishi, S., Onodera, T., Adachi, Y., Sasaki, E., Ishino, K., Morikawa, M., Takei, H., Takahashi, H., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adp9927 · Cited by 27
Evolution of antibody immunity following Omicron BA.1 breakthrough infectionPreprint
Kaku, C. I., Starr, T. N., Zhou, P.-P., Dugan, H. L., Khalifé, P., Song, G., Champney, E. R., Mielcarz, D. W., Geoghegan, J. C., Burton, D. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.21.508922 · Cited by 23
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
Notarbartolo, S. (2024) · Vaccines · doi:10.3390/vaccines12101126 · Cited by 23
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
Cho, A., Muecksch, F., Wang, Z., Tanfous, T. B., DaSilva, J., Raspe, R., Johnson, B., Bednarski, E., Ramos, V., Schaefer-Babajew, D. J., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220732 · Cited by 22
Self-citationRamezani-Rad, P., Marina-Zárate, E., Maiorino, L., Myers, A., Michaels, K. K., Pires, I. S., Bloom, N. I., Melo, M. B., Lemnios, A. A., Lopez, P. G., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185292 · Cited by 21
Research progress in methods for detecting neutralizing antibodies against SARS-CoV-2
Chen, C., Liang, J., Hu, H., Li, X., Wang, L., & Wang, Z. (2023) · Analytical Biochemistry · doi:10.1016/j.ab.2023.115199 · Cited by 22
Self-citationEstablishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms
Pineda-Peña, A.-C., Hasegawa, K., Pavot, V., Berry, C., Combadière, B., Cortés-Garcia, G., McDermott, A. B., & Sridhar, S. (2025) · npj Vaccines · doi:10.1038/s41541-025-01302-x · Cited by 23
Emmenegger, M., Fiedler, S., Brugger, S. D., Devenish, S. R. A., Morgunov, A. S., Ilsley, A., Ricci, F., Malik, A. Y., Scheier, T., Batkitar, L., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104766 · Cited by 20
Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines
Matsumura, T., Takano, T., & Takahashi, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac064 · Cited by 21
Memory B cell development elicited by mRNA booster vaccinations in the elderly
Wang, Z., Muecksch, F., Raspe, R., Johannsen, F., Turroja, M., Canis, M., ElTanbouly, M. A., Santos, G. S. S., Johnson, B., Baharani, V. A., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230668 · Cited by 19
Self-citationZhang, P., Falcone, S., Tsybovsky, Y., Singh, M., Gopan, V., Miao, H., Seo, Y., Rogers, D., Renzi, I., Lai, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305896120 · Cited by 19
Elliott, T., Cheeseman, H. M., Evans, A. B., Day, S., McFarlane, L. R., O’Hara, J., Kalyan, M., Amini, F., Cole, T., Winston, A., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010885 · Cited by 21
Mise‐Omata, S., Ikeda, M., Takeshita, M., Uwamino, Y., Wakui, M., Arai, T., Yoshifuji, A., Murano, K., Siomi, H., Nakagawara, K., et al. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200525 · Cited by 20
Chernyshev, M., Sakharkar, M., Connor, R. I., Dugan, H. L., Sheward, D. J., Rappazzo, C. G., Stålmarck, A., Forsell, M. N. E., Wright, P. F., Corcoran, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37972-1 · Cited by 17
Harnessing mucosal immunity for protective vaccines
Kwon, D.-I., Bhagchandani, S. H., Ehrenzeller, S. A., & Iwasaki, A. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01273-7 · Cited by 25
Verheul, M. K., Nijhof, K. H., de Zeeuw‐Brouwer, M., Duijm, G., ten Hulscher, H. I., de Rond, L., Beckers, L., Eggink, D., van Tol, S., Reimerink, J. H. J., et al. (2023) · Vaccines · doi:10.3390/vaccines11071196 · Cited by 19
Hartley, G. E., Fryer, H. A., Gill, P. A., Boo, I., Bornheimer, S. J., Hogarth, P. M., Drummer, H. E., O’Hehir, R. E., Edwards, E. S. J., & van Zelm, M. C. (2024) · npj Vaccines · doi:10.1038/s41541-024-00919-8 · Cited by 24
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Purbey, P. K., Roy, K., Gupta, S., & Paul, M. K. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.03.009 · Cited by 19
Graham, C., Lechmere, T., Rehman, A., Seow, J., Kurshan, A., Huettner, I., Maguire, T. J. A., Tam, J. C. H., Cox, D., Ward, C. C., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010882 · Cited by 14
Bajpai, P., Singh, V., Chandele, A., & Kumar, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.928279 · Cited by 16
Ling, Z., Yi, C., Sun, X., Yang, Z., & Sun, B. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2215-6 · Cited by 16
Guo, S., Zheng, Y., Gao, Z., Duan, M., Liu, S., Du, P., Xu, X., Xu, K., Zhao, X., Chai, Y., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00585-5 · Cited by 16
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Roederer, A. L., Cao, Y., Denis, K. S., Sheehan, M. L., Li, C. J., Lam, E. C., Gregory, D. J., Poznansky, M. C., Iafrate, A. J., Canaday, D. H., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101850 · Cited by 18
Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination
Qi, F., Cao, Y., Zhang, S., & Zhang, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.964976 · Cited by 16
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccinationPreprint
Schaefer-Babajew, D. J., Wang, Z., Muecksch, F., Cho, A., Raspe, R., Johnson, B. A., Canis, M., DaSilva, J., Ramos, V., Turroja, M., et al. (2022) · medRxiv · doi:10.1101/2022.08.05.22278483 · Cited by 16
Self-citationBai, J., Chiba, A., Murayama, G., Kuga, T., Yahagi, Y., Tabe, Y., Tamura, N., & Miyake, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-24938-4 · Cited by 17
Pradenas, E., Marfil, S., Urrea, V., Trigueros, M., Pidkova, T., Pons-Grífols, A., Ortiz, R., Rovirosa, C., Tarrés-Freixas, F., Aguilar‐Gurrieri, C., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106457 · Cited by 17
Wietschel, K. A., Fechtner, K., Antileo, E., Abdurrahman, G., Drechsler, C. A., Makuvise, M. K., Rose, R., Voß, M., Krumbholz, A., Michalik, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1382911 · Cited by 15
Humoral immunity for durable control of SARS-CoV-2 and its variants
Kotaki, R., Moriyama, S., & Takahashi, Y. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00255-9 · Cited by 15
Morrison, H., Jackson, S., & McShane, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1211388 · Cited by 16
Yu, P., Liu, Z., Zhu, Z., Yang, J., Deng, M., Chen, M., Lai, C., Kong, W., Xiong, S., Wan, L., et al. (2023) · Virologica Sinica · doi:10.1016/j.virs.2022.12.008 · Cited by 14
Metadata
- Authors
- Muecksch, F., Wang, Z., Cho, A., Gaebler, C., Ben Tanfous, T., DaSilva, J., Bednarski, E., Ramos, V., Zong, S., Johnson, B., Raspe, R., Schaefer-Babajew, D., Shimeliovich, I., Daga, M., Yao, K.-H., Schmidt, F., Millard, K. G., Turroja, M., Jankovic, M., Oliveira, T. Y., Gazumyan, A., Caskey, M., Hatziioannou, T., Bieniasz, P. D., & Nussenzweig, M. C.
- Affiliations
- Rockefeller University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Bieniasz, Paul D.
- Nussenzweig, Michel C.
- ORCID
- Muecksch, Frauke
- Wang, Zijun
- Cho, Alice
- Gaebler, Christian
- DaSilva, Justin
- Bednarski, Eva
- Ramos, Victor
- Zong, Shuai
- Johnson, Brianna
- Raspe, Raphael
- Schaefer-Babajew, Dennis
- Shimeliovich, Irina
- Daga, Mridushi
- Yao, Kai-Hui
- Schmidt, Fabian
- Millard, Katrina G.
- Turroja, Martina
- Oliveira, Thiago Y.
- Gazumyan, Anna
- Caskey, Marina
- Hatziioannou, Theodora
- Bieniasz, Paul D.
- Nussenzweig, Michel C.
- Venue
- Nature
- Published
- 2022-04-21
- Volume
- 607
- Issue
- 7917
- Pages
- 128-134
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC9259484
- OpenAlex
- W4224232962
- Cited by
- 297
- References
- 45
- Citations by year
- 2026: 27 · 2025: 39 · 2024: 65 · 2023: 86 · 2022: 80
- FWCI
- 33.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (2U19AI111825, P01-AI138398-S1, UL1 TR001866, R01AI78788, R37-AI64003)
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, Omicron variant, mRNA vaccines, booster vaccination, memory B cells, receptor binding domain, neutralizing antibodies, antibody potency, antibody breadth, B cell clones, longitudinal cohort
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, Memory B Cells, Antibodies, Viral, Humans, Immunization, Secondary, RNA, Messenger, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
